• Home
  • Journal
  • Public Companies
  • Ashland Board appoints Steve D. Bishop, former chief executive officer, Procter and Gamble consumer health care, and Suzan F. Harrison, former president, Colgate-Palmolive global oral care as new directors effective July 1, 2022
Ashland Board appoints Steve D. Bishop, former chief executive officer, Procter and Gamble consumer health care, and Suzan F. Harrison, former president, Colgate-Palmolive global oral care as new directors effective July 1, 2022

Ashland Board appoints Steve D. Bishop, former chief executive officer, Procter and Gamble consumer health care, and Suzan F. Harrison, former president, Colgate-Palmolive global oral care as new directors effective July 1, 2022

William G. Dempsey and Ricky C. Sandler plan exit in January 2023

WILMINGTON, Del., June 10, 2022 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced the appointment of two new directors to its Board as of July 1, 2022: Steve Bishop, former chief executive officer, Procter and Gamble (P&G) consumer health care, and Suzan Harrison, former president, Colgate-Palmolive global oral care.

William Dempsey who has served as a director since 2016, and Ricky Sandler, who joined the board in 2020 have decided not to stand for re-election at Ashland’s Annual Shareholders Meeting in January 2023.

Dempsey is the former executive vice president, global pharmaceuticals, Abbott Laboratories and the current chair of the Board’s governance and nominating committee. He is also a member of the environment, health, safety and quality committee. Sandler is the founder and chief executive officer and chief investment officer of Eminence Capital. He is a member of both the audit and governance and nominating committee.

To allow for an orderly transition, the addition of Bishop and Harrison temporarily increases the size of the Board from nine to 11 members until the next Annual Shareholders Meeting in January 2023.

Steve Bishop is the recently retired chief executive officer of P&G consumer health care. In this capacity, he led the $11 billion consumer health care reportable unit. Previously, he served in president or group president roles across other P&G global operating units. He is a disciplined, results oriented leader who has a deep passion for innovation. As a mentor to several executives, he also supported the personal development of women and minorities and enabled broader executive level diversity in the company. Bishop is a graduate of Purdue University, where he obtained a Bachelor of Science degree in Agricultural Economics.

Suzan Harrison has held a variety of leadership positions at the Colgate-Palmolive Company. She was named president, global oral care in 2011, a position she held until her retirement in 2019. Previously, she was president, Hill’s Pet Nutrition Inc. North America, and held other senior leadership positions, including vice president, marketing, for Colgate U.S., and vice president and general manager of Colgate Oral Pharmaceuticals, North America and Europe. She has strong operational experience in consumer products and a passion for sustainability. Harrison is a member of the Board of Directors of WestRock Company, and ADM where she chairs the Sustainability and Social Responsibility committee. Harrison holds a Master of Business Administration degree from New York University and a Bachelor of Science degree from Binghamton University.

“I am excited to welcome Steve and Suzan as new directors to the Ashland Board, and I am confident they will provide valuable perspectives as we continue to execute our strategy, drive profitability, and enhance value for our shareholders,” said Guillermo Novo, chair and chief executive officer, Ashland.

To learn more, visit investor.ashland.com

About Ashland 
Ashland Global Holdings Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for sustainability. The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceuticals. Approximately 3,800 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex
problems for customers in more than 100 countries. Visit ashland.com and ashland.com/sustainability to learn more. 

Trademark, Ashland or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations: Media Relations:
Seth A. Mrozek Carolmarie C. Brown
+1 (302) 594-5010 +1 (302) 995-3158
samrozek@ashland.com ccbrown@ashland.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.